August 15, 2024 Panacea Biotec and ICMR initiate Phase III Clinical Trial of DengiAll clinicaltrials Dengue
July 2, 2024 DCVMN CEO in the “2nd Edition of The Global Event on Harnessing Private Sector Engagement for Sustainable Vaccine and Pharmaceutical Manufacturing in Africa” Africa DCVMN Advocacy Vaccines & immunization WeConnectToProtect
June 28, 2024 Regulatory Working Group Workshop on Next-Generation Sequencing (NGS) technology DCVMN achievements DCVMN Working Groups Vaccines & immunization